GenXys Company Overview
GenXys is a prominent provider of precision prescribing software and pharmacogenomic tests, catering to both consumers and healthcare professionals. The company's cutting-edge medication decision support solutions enable care teams to deliver high-quality, evidence-based care at reduced costs, from medication reviews to the point of prescribing. GenXys' focus on leveraging pharmacogenetic data to inform prescription decisions has led to improvements in patient safety and reduced costs in the delivery of personalized medicine. The company's commitment to precision medication management and actionable genetic insights has positioned it as a global leader in the field of precision prescribing software
GenXys Valuation History
GenXys Stock Price
The stock price of GenXys can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.
For illustrative purposes, however, assuming GenXys has issued 250 million shares, at the estimated UpMarket valuation of $12.15 million, each share of GenXys stock would be worth $0.05.
Buy GenXys Stock
If you would like to buy shares in GenXys, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”
One of our investor relations team members will contact you to discuss GenXys stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.
UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, GenXys as well.
GenXys Management
| Name | Position |
|---|---|
| Martin Dawes | CEO |
